<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cardiovasc. Med.</journal-id>
<journal-title>Frontiers in Cardiovascular Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cardiovasc. Med.</abbrev-journal-title>
<issn pub-type="epub">2297-055X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcvm.2023.1082015</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cardiovascular Medicine</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>PILRA is associated with immune cells infiltration in atrial fibrillation based on bioinformatics and experiment validation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes"><name><surname>Shi</surname><given-names>Weihua</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="an1"><sup>&#x2020;</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/2002448/overview"/></contrib>
<contrib contrib-type="author" equal-contrib="yes"><name><surname>Li</surname><given-names>Xiaoli</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="an1"><sup>&#x2020;</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/2075123/overview" /></contrib>
<contrib contrib-type="author"><name><surname>Su</surname><given-names>Yongxing</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author"><name><surname>Liu</surname><given-names>Dezhao</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author"><name><surname>Wu</surname><given-names>Liying</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author"><name><surname>Li</surname><given-names>Shuo</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author"><name><surname>He</surname><given-names>Wenxiu</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Zhong</surname><given-names>Guoqiang</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/2170676/overview" /></contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Jiang</surname><given-names>Zhiyuan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/2072393/overview" /></contrib>
</contrib-group>
<aff id="aff1"><label><sup>1</sup></label><addr-line>Department of Cardiology</addr-line>, <institution>First Affiliated Hospital, Guangxi Medical University</institution>, <addr-line>Nanning</addr-line>, <country>China</country></aff>
<aff id="aff2"><label><sup>2</sup></label><addr-line>Department of Pharmacy</addr-line>, <institution>Guangxi Zhuang Autonomous Region People&#x2019;s Hospital</institution>, <addr-line>Nanning</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p><bold>Edited by:</bold> Rui Provid&#x00EA;ncia University College of London, United Kingdom</p></fn>
<fn fn-type="edited-by"><p><bold>Reviewed by:</bold> Xiaorong Hu, Wuhan University, China Emanuele Micaglio, IRCCS San Donato Polyclinic, Italy</p></fn>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> Zhiyuan Jiang <email>mr_jzy@163.com</email> Guoqiang Zhong <email>gq_zhong@126.com</email></corresp>
<fn fn-type="equal" id="an1"><label><sup>&#x2020;</sup></label><p>These authors have contributed equally to this work and share first authorship</p></fn>
</author-notes>
<pub-date pub-type="epub"><day>16</day><month>06</month><year>2023</year></pub-date>
<pub-date pub-type="collection"><year>2023</year></pub-date>
<volume>10</volume><elocation-id>1082015</elocation-id>
<history>
<date date-type="received"><day>27</day><month>10</month><year>2022</year></date>
<date date-type="accepted"><day>05</day><month>06</month><year>2023</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2023 Shi, Li, Su, Liu, Wu, Li, He, Zhong and Jiang.</copyright-statement>
<copyright-year>2023</copyright-year><copyright-holder>Shi, Li, Su, Liu, Wu, Li, He, Zhong and Jiang</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<sec><title>Background and aims</title>
<p>inflammation plays an important role in atrial fibrillation (AF). In this study, we investigated the significance of immune cell infiltration in AF and identified the potential Hub genes involved in the regulation of immune cell infiltration in AF.</p>
</sec>
<sec><title>Methods</title>
<p>we obtained AF datasets from the GEO database and analyzed them for obtaining differentially expressed genes (DEGs) by R software. Then, we performed GO, KEGG, and GSEA enrichment analyses of DEGs. The Hub genes of AF were determined by least absolute shrinkage selection operator (LASSO) regression analysis and weighted gene co-expression network analysis (WGCNA). Their validation was verified by using quantitative polymerase chain reaction (qPCR) in the AF rat model. Finally, we used a single sample GSEA (ssGSEA) to analyze immune cell infiltration and its relationship with hub genes.</p>
</sec>
<sec><title>Results</title>
<p>We obtained 298 DGEs from the heatmap and found that DGEs were closely related to inflammation, immunity, and cytokine interactions by enrichment analyses. We obtained 10 co-expression modules by WGCNA. Among them, the module including CLEC4A, COTL1, EVI2B, FCER1G, GAPT, HCST, NCF2, PILRA, TLR8, and TYROBP had the highest correlation with AF. Four Hub genes (PILRA, NCF2, EVI2B, GAPT) were obtained further by LASSO analysis. The results suggested that the expression level of PILRA was significantly elevated in the rats with AF by qPCR, compared to the rats without AF. The results revealed that the infiltration of neutrophils, macrophages, monocytes, mast cells, immature B cells, myeloid-derived suppressor cell (MDSC), dendritic cell, and T cells and their partial subpopulations were closely related to AF by ssGSEA analysis, and PILRA was positively correlated with immature B cell, monocyte, macrophage, mast cell, dendritic cell, and T cells and their partial subpopulations by Spearman correlation analysis.</p>
</sec>
<sec><title>Conclusions</title>
<p>PILRA was closely related to multiple types of immune cell infiltration, which may be associated with AF. PILRA may be a novel target of intervention for AF.</p>
</sec>
</abstract>
<kwd-group>
<kwd>atrial fibrillation</kwd>
<kwd>inflammation</kwd>
<kwd>immune cells 1nfiltration</kwd>
<kwd>weighted gene co-expression network analysis (WGCNA)</kwd>
<kwd>least absolute shrinkage selection operator (LASSO) regression analysis</kwd>
</kwd-group>
<contract-num rid="cn001">82060068, 82160066</contract-num>
<contract-sponsor id="cn001">National Natural Sciences Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content></contract-sponsor>
<counts>
<fig-count count="10"/>
<table-count count="2"/><equation-count count="0"/><ref-count count="32"/><page-count count="0"/><word-count count="0"/></counts><custom-meta-wrap><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Cardiac Rhythmology</meta-value></custom-meta></custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro"><label>1.</label><title>Introduction</title>
<p>Atrial fibrillation (AF) is the most common tachyarrhythmia (<xref ref-type="bibr" rid="B1">1</xref>), which increases the risk of heart failure and stroke, and is correlated with significantly increased mortality and morbidity (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>).</p>
<p>Currently, the atrial remolding including the structural and electrical remodeling is considered to play a crucial role in the pathogenesis of AF (<xref ref-type="bibr" rid="B4">4</xref>). The presence of inflammation in the heart or systemic circulation can predict the occurrence and recurrence of AF in the general population, as well as in patients after cardiac surgery, cardioversion, and catheter ablation. Moreover, increasing evidences indicate that there is a close correlation between inflammation and AF (<xref ref-type="bibr" rid="B5">5</xref>). Activation of NLRP3 inflammasome was observed in atrial cardiomyocytes of patients with paroxysmal and chronic AF, and the activation of NLRP3 inflammasome promoted AF by recruiting the immune cells and enhancing atrial structural and electrical remodeling (<xref ref-type="bibr" rid="B6">6</xref>). The infiltration of immune cells mediates the inflammatory response in cardiac tissue and provides substrates for AF-maintaining (<xref ref-type="bibr" rid="B7">7</xref>). However, the regulatory mechanism of the infiltration of immune cells in the atrial tissue of patients with AF is still not fully elucidated.</p>
<p>Weighted gene co-expression network analysis (WGCNA) and least absolute shrinkage selection operator (LASSO) regression analysis are important methods in bioinformatics. WGCNA can be used to find clusters of highly correlated genes, and summarize such clusters with the module eigengene or an intramodular hub gene, in order to relate modules to one another and to external sample traits (using eigengene network methodology), and to calculate module membership measures. It can improve stability of identification for candidate biomarkers or therapeutic targets (<xref ref-type="bibr" rid="B8">8</xref>). LASSO regression analysis is a shrinkage and variable selection method for linear regression models that can improve the selection and classification of relevant variables, compared to the traditional Cox regression and logistic regression (<xref ref-type="bibr" rid="B9">9</xref>). WGCNA and LASSO regression analysis could improve the accuracy of screening for disease Hub genes.</p>
<p>In this study, we explored the key differential genes of immune cells infiltration in AF using WGCNA and LASSO regression analysis simultaneously, aimed to provide new insights for mechanism of immune cells infiltration in AF, and to look for potential therapeutic targets for AF.</p>
</sec>
<sec id="s2"><label>2.</label><title>Materials and methods</title>
<sec id="s2a"><label>2.1.</label><title>Data collection</title>
<p>The study flowchart was shown in <xref ref-type="fig" rid="F1">Figure&#x00A0;1</xref>. The datasets (GSE41177 and GSE79768) were obtained from the Gene Expression Omnibus database (GEO, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/">http://www.ncbi.nlm.nih.gov/geo/</ext-link>), There are 14 AF samples and 12 sinus rhythm samples from 7 patients with AF and 6 patients with sinus rhythm in the dataset GSE79768 (GPL570 HG-U133_Plus_2 Affymetrix Human Genome U133 Plus 2.0 Array) (<xref ref-type="bibr" rid="B10">10</xref>), and 32 AF samples and 6 sinus rhythm samples from 16 patients with AF and 3 patients with sinus rhythm in the dataset GSE41177 (GPL570 HG-U133_Plus_2 Affymetrix Human Genome U133 Plus 2.0 Array) (<xref ref-type="bibr" rid="B11">11</xref>). Therefore, 46 AF samples and 18 sinus rhythm samples from 23 patients with AF and 9 patients with sinus rhythm were included in our analysis. Of note, left atrial tissue sample and right atrial tissue sample were respectively obtained from every patient in the dataset GSE79768, and tissue sample in left atrial appendage and tissue sample in left atrium-pulmonary vein junction were respectively obtained from every patient in the dataset GSE41177.</p>
<fig id="F1" position="float"><label>Figure 1</label>
<caption><p>The study flowchart of data collection, analysis, processing, and experimental validation.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-10-1082015-g001.tif"/>
</fig>
<p>Subsequently, the normalization of the datasets was performed using the &#x201C;SVA&#x201D; package. We first read the genes information of two datasets to obtain each gene symbol. When different expression values were presented in a same gene, the mean values were calculated. Logarithmic transformation was performed for the non-logarithmic value of genes expression. Then, two datasets were combined and internally normalized. Finally, the normalization of the dataset was output.</p>
<p>The protocols of 2 studies analyzed in our study were conducted according to the Helsinki Declaration, and obtained the ethical approval. All patients enrolled in the 2 studies were given written informed consent (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>).</p>
</sec>
<sec id="s2b"><label>2.2.</label><title>Acquisition of DEGs</title>
<p>The genes were analyzed by using &#x201C;limma&#x201D; package in R software, thresholded at &#x007C;logFC&#x007C;&#x2009;&#x003E;&#x2009;0.5 and adjusted <italic>p</italic> value &#x003C;0.05. When different expression values were presented in a same gene, the mean values were calculated. When the genes expression values were 0, the genes were excluded. Then, the differential expression genes (DEGs) between samples with AF and sinus rhythm were obtained, when adjusted <italic>p</italic> values &#x003C;0.05 correcting for the false discovery rate method (<xref ref-type="bibr" rid="B12">12</xref>). Finally, the DEGs were output and visualized by heatmap.</p>
</sec>
<sec id="s2c"><label>2.3.</label><title>Enrichment analysis of DEGs</title>
<p>We then performed GO, KEGG, and GSEA enrichment analyses of DEGs by using &#x201C;clusterProfiler and enrichplot&#x201D; packages, and the immunological signature genome was used as a reference for GSEA. A <italic>p</italic> value &#x003C;0.05 was considered statistically significant.</p>
</sec>
<sec id="s2d"><label>2.4.</label><title>Genes co-expression network analysis</title>
<p>We constructed a weighted co-expression network using the WGCNA package to normalize the expression profiles of GSE41177 and GSE79768 batches. We checked the data by using &#x201C;goodSampleGenes&#x201D; and used the &#x201C;pickSoftThreshold&#x201D; function to obtain the appropriate soft threshold (<italic>&#x03B2;</italic>), then created a scale-free topology network while converting the matrix data into an adjacency matrix. After calculating module eigengene (ME) and merging similar modules in the clustering tree according to ME, we obtained a hierarchical clustering dendrogram. Gene significance (GS) and module significance (MS), which were used to measure genetic and clinical information, were calculated, and the correlations between modules and models were analyzed. Finally, we calculated the module membership (MM) for each gene to analyze the GS in the modules.</p>
</sec>
<sec id="s2e"><label>2.5.</label><title>Screening of hub genes</title>
<p>We chose the LASSO regression algorithm to identify important variables as well as to improve the accuracy of prediction. The central genes with the lowest <italic>p</italic> value, high inter-module connectivity with &#x007C;GS&#x007C;&#x2009;&#x003E;&#x2009;0.50, and &#x007C;MM&#x007C;&#x2009;&#x003E;&#x2009;0.80, were firstly selected for screening of hub genes. Then, &#x201C;Venn&#x201D; package was used to intersect the central genes with DEGs. Finally, hub genes were obtained via &#x201C;glmnet&#x201D; analysis.</p>
</sec>
<sec id="s2f"><label>2.6.</label><title>Validation of hub genes</title>
<p>We used the &#x201C;ggpubr&#x201D; package to construct box plots to assess hub genes expression levels between patients with AF and sinus rhythm, and plotted receiver operating characteristic curves (ROC) were used to analyze the accuracy of the hub gene for diagnosis by the &#x201C;pROC&#x201D; package.</p>
</sec>
<sec id="s2g"><label>2.7.</label><title>Quantitative polymerase chain reaction</title>
<p>We constructed an animal AF model using the rats with transverse aortic constriction (TAC) (<xref ref-type="bibr" rid="B13">13</xref>&#x2013;<xref ref-type="bibr" rid="B15">15</xref>). Meanwhile, the rats without TAC were used as control group. Eight rats were included in AF group, and 7 rats were included in control group. The temperature, appetite, and weight were detected in rats in each group in everyday, to exclude infectious diseases and heart failure. One month after TAC, the rats in each group were anesthetized and fixed supinely on an animal test bench. Then, vulnerability to AF of the rats in each group were measured by 3 cyclically transesophageal burst atrial pacing at a frequency of 1,500&#x2005;stimuli/min for 30&#x2005;s, with 5&#x2005;min interval between cycles.</p>
<p>The experimental protocols were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals, and were approved by the Ethics Committee of Guangxi Medical University Laboratory Animal Center (N&#x1ECD;: 202207002).</p>
<p>The atrial tissue of rats in each group were collected after measurement of vulnerability to AF, and were snap frozen in liquid nitrogen for RNA isolation. Total RNA was extracted from the tissue using RNA extraction reagent (Servicebio, Wuhan, China). The concentration and purity of the extracted RNA were detected using an ultra-microspectrophotometer (Thermo Fisher Scientific, Massachusetts, USA). 1&#x2005;&#x03BC;g of total RNA was reverse transcribed into cDNA using the Prime Script&#x2122; RT reagent Kit with gDNA Eraser (Takara, Tokoyo, Japan). The quantitative polymerase chain reaction (qRCR) procedure was carried out as follows: 95&#x00B0;C for 30&#x2005;s, 95&#x00B0;C for 5&#x2005;s, and 60&#x00B0;C for 30&#x2005;s for 40 cycles. Melt-curve analysis was performed at 65&#x2013;95&#x00B0;C. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as the internal control for normalizing gene expression. The data obtained were calculated by the 2<sup>&#x2013;&#x0394;&#x0394;Ct</sup> method (<xref ref-type="bibr" rid="B16">16</xref>). The sequences of primers were shown in <xref ref-type="table" rid="T1">Table&#x00A0;1</xref>.</p>
<table-wrap id="T1" position="float"><label>Table 1</label>
<caption><p>The sequences of primers for qPCR.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Genes Name</th>
<th valign="top" align="center">Forward (5&#x0027;&#x2013;3&#x0027;)</th>
<th valign="top" align="center">Reverse (3&#x0027;&#x2013;5&#x0027;)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">PILRA</td>
<td valign="top" align="left">GATTGACAGTGTTCCTCGGGTG</td>
<td valign="top" align="left">CTAGGTGCTGCTCCTGGTGA</td>
</tr>
<tr>
<td valign="top" align="left">NCF2</td>
<td valign="top" align="left">TAGGCTGTTCCGTCCAAATGA</td>
<td valign="top" align="left">AACCGTAGCCTTGCCCAGATA</td>
</tr>
<tr>
<td valign="top" align="left">GAPT</td>
<td valign="top" align="left">CAGCAGGCATAAAGACTACACGA</td>
<td valign="top" align="left">CAGTAGATTTCTGGCCTTTGCTT</td>
</tr>
<tr>
<td valign="top" align="left">EVI2B</td>
<td valign="top" align="left">AAAACCTATCAGACAAGCCCACA</td>
<td valign="top" align="left">GGCTCGTTGATCTGGGAATG</td>
</tr>
<tr>
<td valign="top" align="left">GAPDH</td>
<td valign="top" align="left">CTGGAGAAACCTGCCAAGTATG</td>
<td valign="top" align="left">GGTGGAAGAATGGGAGTTGCT</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2h"><label>2.8.</label><title>Immune cell infiltration</title>
<p>The ssGSEA algorithm was used to analyze the proportion of 28 types of immune cells in the immune infiltrative microenvironment of AF, the &#x201C;vioplot&#x201D; package was used to assess the immune cells infiltration between AF and control group, and Spearman correlation analysis was used to calculate the correlation between Hub genes expression and the proportion of immune cells infiltration.</p>
</sec>
<sec id="s2i"><label>2.9.</label><title>Statistical analysis</title>
<p>qPCR data were analyzed using SPSS 23.0 software (SPSS Inc., Chicago, IL, USA). Two unpaired Student&#x0027;s <italic>t</italic>-test was performed to compare the difference between AF group and control group. All the results of qPCR in the study were visualized by graph pad Prism 8 (GraphPad Software, Inc., San Diego CA, USA). A <italic>p</italic> value &#x003C;0.05 was considered statistically significant. All other statistical analyses were performed using R software version 4.1.0 (<ext-link ext-link-type="uri" xlink:href="www.r-project.org/">www.r-project.org/</ext-link>).</p>
</sec>
</sec>
<sec id="s3" sec-type="results"><label>3.</label><title>Results</title>
<sec id="s3a"><label>3.1.</label><title>Identification of DEGs</title>
<p>After the datasets were merged and normalized, a total of 298 DEGs were obtained. The results were shown in <xref ref-type="fig" rid="F2">Figure&#x00A0;2</xref>.</p>
<fig id="F2" position="float"><label>Figure 2</label>
<caption><p>Identification differential expression genes of atrial fibrillation (<bold>A</bold>) heatmap of DGEs. (<bold>B</bold>) Volcano map of DGEs.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-10-1082015-g002.tif"/>
</fig>
</sec>
<sec id="s3b"><label>3.2.</label><title>Enrichment analysis of DEGs</title>
<p>To understand the biological functions and signaling pathways associated with AF, we performed the differential enrichment analysis. GO enrichment analysis revealed that DEGs were associated with neutrophil degranulation, neutrophil activation involved in immune response, immune receptor activity, RAGE receptor binding, and collagen-containing extracellular matrix (<xref ref-type="fig" rid="F3">Figure&#x00A0;3A</xref>). KEGG enrichment analysis showed that DEGs were associated with cytokine-cytokine receptor interactions, chemokine signaling pathways and B cell receptor signaling pathways, etc. (<xref ref-type="fig" rid="F3">Figure&#x00A0;3B</xref>). The MsigDB database of the immune signature gene set was referenced for the GSEA to explore the potential mechanisms of immune function in AF. GSEA revealed that DEGs were significantly enriched in B cells, CD<sup>4&#x002B;</sup> T cells, CD<sup>8&#x002B;</sup> T cells (<xref ref-type="fig" rid="F3">Figure&#x00A0;3C</xref>).</p>
<fig id="F3" position="float"><label>Figure 3</label>
<caption><p>Enrichment analysis of DGEs in AF. (<bold>A</bold>) Gene ontology (GO) analysis of DEGs. (<bold>B</bold>) Kyoto encyclopedia of genes and genomes (KEGG) analysis of DEGs. (<bold>C</bold>) Gene set enrichment analysis (GSEA) of DEGs.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-10-1082015-g003.tif"/>
</fig>
</sec>
<sec id="s3c"><label>3.3.</label><title>Construction of co-expression network</title>
<p>We used the WGCNA package to construct a gene co-expression network. After the samples were clustered to handle missing values and remove outliers, a scale-independent topological network was built (soft threshold <italic>&#x03B2;</italic>&#x2009;&#x003D;&#x2009;7, scale-free <italic>R</italic><sup>2</sup>&#x2009;&#x003D;&#x2009;0.83; slope&#x2009;&#x003D;&#x2009;&#x2212;1.59). A co-expression matrix was also constructed using a one-step method. Mixed cuts were made to construct a hierarchical clustering tree, and 10 gene modules were subsequently obtained by fusion of similar modules.</p>
<p>The correlation of the above modules with AF or sinus rhythm was clarified using heatmap. The results indicated that the module (including CLEC4A, COTL1, EVI2B, FCER1G, GAPT, HCST, NCF2, PILRA, TLR8, and TYROBP) had the highest correlation with AF (<italic>&#x03C1;</italic>&#x2009;&#x003D;&#x2009;0.48, <italic>p</italic>&#x2009;&#x003D;&#x2009;5&#x2009;&#x00D7;&#x2009;10<sup>&#x2212;5</sup>) (<xref ref-type="fig" rid="F4">Figure&#x00A0;4</xref>). Furthermore, there was a good correlation between GS and MM in this module (<italic>&#x03C1;</italic>&#x2009;&#x003D;&#x2009;0.42, <italic>p&#x2009;</italic>&#x003D;&#x2009;3.4&#x2009;&#x00D7;&#x2009;10<sup>&#x2212;24</sup>). Therefore, we finally chose this module as the candidate module.</p>
<fig id="F4" position="float"><label>Figure 4</label>
<caption><p>Construction of weighted gene co-expression network analysis (WGCNA) modules in AF. (<bold>A</bold>) The original and combined modules of tree diagram. (<bold>B</bold>) The black module has the highest correlation with AF in the heatmap of module-trait relationships. Red: positive correlations with AF; blue: negative correlations with AF. (<bold>C</bold>) The candidate genes contributing to AF in the black model shown in Scatter plot. When &#x007C;GS&#x007C; was more than 0.50 and &#x007C;MM&#x007C; was more than 0.80, the genes were chosen as the candidate genes. GS, gene significance; MM, module membership.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-10-1082015-g004.tif"/>
</fig>
</sec>
<sec id="s3d"><label>3.4.</label><title>Screening of hub genes</title>
<p>Ten genes from the black module were obtained using &#x007C;GS&#x007C;&#x2009;&#x003E;&#x2009;0.50 and &#x007C;MM&#x007C;&#x2009;&#x003E;&#x2009;0.80 as a cutoff value, and analyzed using the LASSO algorithm. The 4 hub genes including PILRA, NCF2, EVI2B, and GAPT were obtained finally by LASSO regression analysis after intersecting with DEGs (<xref ref-type="fig" rid="F5">Figure&#x00A0;5</xref>).</p>
<fig id="F5" position="float"><label>Figure 5</label>
<caption><p>Least absolute shrinkage selection operator (LASSO) regression analysis of DGEs in AF. (<bold>A</bold>) Venn diagram of crossover genes between DEGs and candidate modules. (<bold>B</bold>) The trend of coefficient distribution of cross-validation. Four genes (PILRA, NCF2, EVI2B and GAPT) were obtained in the optimal <italic>&#x03BB;</italic> value. (<bold>C</bold>) Distribution of pivotal genes in Lasso regression analysis.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-10-1082015-g005.tif"/>
</fig>
</sec>
<sec id="s3e"><label>3.5.</label><title>Expression levels and diagnostic effectiveness of hub genes</title>
<p>We used box plots to verify the expression levels of the 4 Hub genes, the results presented in <xref ref-type="fig" rid="F6">Figure&#x00A0;6</xref> suggested that the expression of PILRA, NCF2, EVI2B, and GAPT were higher in atrial tissue of patients with AF, compared to those in atrial tissue of patients with SR. To verify whether the 4 hub genes have a good diagnostic value, we computed the values of the area under the curve (AUC) of the Hub genes. The AUC values of PILRA, NCF2, EVI2B, and GAPT were 0.856, 0.890, 0.861, and 0.862, respectively (<xref ref-type="fig" rid="F7">Figure&#x00A0;7</xref>). These results indicated that these genes had a good diagnostic value for AF.</p>
<fig id="F6" position="float"><label>Figure 6</label>
<caption><p>Elevated expression levels of PILRA, EVI2B, NCF2, and GAPT in atrial tissue of patients with AF from GSE41177 and GSE79768. (<bold>A</bold>) The expression of PILRA in patients with AF and patients with sinus rhythm. (<bold>B</bold>) The expression of EVI2B in patients with AF and patients with sinus rhythm. (<bold>C</bold>) The expression of NCF2 in patients with AF and patients with sinus rhythm. (<bold>D</bold>) The expression of GAPT in patients with AF and patients with sinus rhythm. Con: the patients with sinus rhythm. AF: the patients with AF. (&#x002A;&#x002A;&#x002A;<italic>p&#x2009;</italic>&#x003C;&#x2009;0.001; &#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.01; &#x002A;<italic>p&#x2009;</italic>&#x003C;&#x2009;0.05).</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-10-1082015-g006.tif"/>
</fig>
<fig id="F7" position="float"><label>Figure 7</label>
<caption><p>Area under curve (AUC) of the Hub genes for diagnosis of AF. (<bold>A</bold>) AUC value of PILRA. (<bold>B</bold>) AUC value of GAPT. (<bold>C</bold>) AUC value of NCF2. (<bold>D</bold>) AUC value of EVI2B.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-10-1082015-g007.tif"/>
</fig>
</sec>
<sec id="s3f"><label>3.6.</label><title>The expression levels of 4 hub genes in AF rat model</title>
<p>The expression levels of 4 hub genes in rats with AF and sinus rhythm were measured by qPCR. There were 7 rats in Control group and 8 rats in AF group. Two rats in AF group with TAC were dead of heart failure. Finally, 7 rats in control group and 6 rats in AF group were performed transesophageal burst atrial pacing to measure the vulnerability of AF. The electrocardiograms of rats in control and AF groups were shown in <xref ref-type="fig" rid="F8">Figure 8</xref>. The results have been shown in <xref ref-type="table" rid="T2">Table&#x00A0;2</xref>. One rat in Control group was dead after transesophageal burst pacing. The expression levels of PILRA were measured in 6 rats in each group, and expression of NCF2, EVI2B, and GAPT were measured in 5 rats in each group. The results shown in <xref ref-type="fig" rid="F9">Figure&#x00A0;9</xref> revealed that the expression level of PILRA was significantly elevated in rats with AF, compared to those in rats with SR, but the expression levels of NCF2, EVI2B, and GAPT were no obvious difference between the rats with AF and the rats with SR. These results further proved that PILRA may be a potential target for intervention of AF.</p>
<fig id="F8" position="float"><label>Figure 8</label>
<caption><p>The electrocardiogram of rat with sinus rhythm (SR) or AF. (<bold>A</bold>) The representative electrocardiogram of rats with SR. <italic>p</italic> wave and regular R&#x2013;R interval could be observed. (<bold>B</bold>) The representative electrocardiogram of rats with AF. <italic>p</italic> wave disappeared and was replaced by a disordered <italic>f</italic> wave with absolutely irregular R&#x2013;R intervals. EB: transesophageal burst pacing.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-10-1082015-g008.tif"/>
</fig>
<fig id="F9" position="float"><label>Figure 9</label>
<caption><p>Relative mRNA expression levels of Hub genes. (<bold>A</bold>) PILRA expression level in rats with or without AF. (<bold>B</bold>) EVI2B expression level in rats with or without AF. (<bold>C</bold>) GAPT expression level in rats with or without AF. (<bold>D</bold>) NCF2 expression level in rats with or without AF. (&#x002A;&#x002A;<italic>p&#x2009;</italic>&#x003C;&#x2009;0.01; ns, no significant difference).</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-10-1082015-g009.tif"/>
</fig>
<table-wrap id="T2" position="float"><label>Table 2</label>
<caption><p>The inducibility and duration of atrial fibrillation (AF) by transesophageal burst atrial pacing in control and AF group.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Group</th>
<th valign="top" align="center">Inducibility of AF</th>
<th valign="top" align="center">AF duration &#x2264;45&#x2005;s</th>
<th valign="top" align="center">AF duration &#x2265;249&#x2005;s</th>
<th valign="top" align="center">AF duration &#x2265;500&#x2005;s</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Control (<italic>n</italic>&#x2009;&#x003D;&#x2009;7)</td>
<td valign="top" align="center">1 (14.3&#x0025;)</td>
<td valign="top" align="center">1 (14.3&#x0025;)</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
</tr>
<tr>
<td valign="top" align="left">AF (<italic>n</italic>&#x2009;&#x003D;&#x2009;6)</td>
<td valign="top" align="center">6 (100&#x0025;)</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">5 (83.3&#x0025;)</td>
<td valign="top" align="center">1 (16.7&#x0025;)</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3g"><label>3.7.</label><title>Assessment of immune cells infiltration</title>
<p>We used the ssGSEA to explore the different types of immune cells between AF and SR, and evaluate their relationship. The distribution of immune cells in AF and SR, shown in <xref ref-type="fig" rid="F10">Figures&#x00A0;10A,B</xref> revealed that immunity had a correlation with AF. Activated CD<sup>4</sup> T cell (<italic>p&#x2009;</italic>&#x003D;&#x2009;0.019), Activated CD<sup>8</sup> T cell (<italic>p&#x2009;</italic>&#x003D;&#x2009;0.024), Activated dendritic cell (<italic>p&#x2009;</italic>&#x003D;&#x2009;0.002), Gamm delta T cell (<italic>p&#x2009;</italic>&#x003D;&#x2009;0.016), Immature B cell (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001), myeloid-derived suppressor cell (MDSC) (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001), Macrophage (<italic>p&#x2009;</italic>&#x003D;&#x2009;0.001), Mast cell (<italic>p&#x2009;</italic>&#x003D;&#x2009;0.001), Monocyte (<italic>p&#x2009;</italic>&#x003D;&#x2009;0.002), Neutrophil (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001), Plasmacytoid dendritic cell (<italic>p&#x2009;</italic>&#x003D;&#x2009;0.003), Regulatory T cell (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001), Type 17 T helper cell (<italic>p&#x2009;</italic>&#x003D;&#x2009;0.001), Effector memory CD<sup>4</sup> T cell (<italic>p&#x2009;</italic>&#x003D;&#x2009;0.005), Central memory CD<sup>4</sup> T cell (<italic>p&#x2009;</italic>&#x003D;&#x2009;0.008), Central memory CD<sup>8</sup> T cell (<italic>p&#x2009;</italic>&#x003D;&#x2009;0.001) and Effector Memory CD<sup>8</sup> T cell (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001) were positively correlated with AF (<xref ref-type="fig" rid="F10">Figure&#x00A0;10C</xref>).</p>
<fig id="F10" position="float"><label>Figure 10</label>
<caption><p>The association of PILRA with immune cell infiltration in AF. (<bold>A</bold>) Heatmap of immune cell infiltration in AF. (<bold>B</bold>)Violin plot showed the correlation between immune cells infiltration and AF. (<bold>C</bold>) The relationship between immune cells infiltration and PILRA.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-10-1082015-g010.tif"/>
</fig>
<p>The Spearman correlation analysis showed that PILRA was significantly and positively correlated with Immature B cell (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.01), dendritic cell (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001), Myeloid&#x2013;derived suppressor cell (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001), mast cell (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.01), macrophage (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001), and T cells and their subpopulations (including Regulatory T cell, Effector memory CD<sup>8</sup> T cell, Effector memory CD<sup>4</sup> T cell, Central memory CD<sup>4</sup> T cell, Activated CD<sup>8</sup> T cell, Activated CD<sup>4</sup> T cell (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001), Gamma delta T cell (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.01), Central memory CD<sup>8</sup> T cell (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05). These results suggested that PILRA may play a crucial role in regulation of immune cells infiltration that enhanced inflammatory response to promote AF, and PILRA may be a novel target for intervention of AF.</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion"><label>4.</label><title>Discussion</title>
<p>In this study, we integrated two AF microarray datasets from GEO to identify the Hub genes associated with immune infiltration in AF. 298 DEGs were obtained after the 2 datasets were merged and normalized. The DEGs were significantly associated with adhesion and infiltration of immune cells, and immune response by GO enrichment analysis, KEGG enrichment analysis, and GSEA enrichment analysis, respectively. Then, the module that had the highest correlation with AF was obtained by WGCNA. Subsequently, the genes from the module were analyzed by LASSO regression analysis. The results highlighted that PILRA, NCF2, EVI2B, and GAPT may be the Hub genes. Furthermore, we detected the expression of 4 Hub genes by qPCR. We found that only expression level of PILRA was elevated in AF rat model, compared to those in sinus rhythm rat model, and PILRA was significantly and positively correlated with infiltration of multiple types of immune cells that were involved in AF. Taken together, our results suggested that PILRA may play a crucial role in regulation of immune cells infiltration that enhanced inflammatory response to promote AF, and PILRA may be a novel target for intervention of AF.</p>
<p>Interestingly, most of the DEGs were related to adhesion and infiltration of immune cells, and immune response by GO enrichment analysis, KEGG enrichment analysis, and GSEA enrichment analysis, respectively. This indicates that inflammation plays an important role in initiation and perpetuation of AF. KEGG enrichment analysis showed that DEGs were associated with cytokine-cytokine receptor interactions, chemokine signaling pathways, and B cell receptor signaling pathways. Cytokines are a class of proteins in inflammatory signaling pathway including chemokines, interleukins, and tumor necrosis factors-&#x03B1; (TNF-&#x03B1;) (<xref ref-type="bibr" rid="B17">17</xref>). TNF-&#x03B1; was associated with the pathogenesis of chronic AF, and increased levels of TNF-&#x03B1; and atrial fibrosis were often detected in AF patients with valvular heart disease (<xref ref-type="bibr" rid="B18">18</xref>). Systemic inflammation with elevated serum levels of interleukin 6, induced atrial electrical remodeling through the downregulation of cardiac connexins, and increased the risk of AF (<xref ref-type="bibr" rid="B19">19</xref>). Chemokines are a large family of small, inducible, secreted proteins that bind to G-protein&#x2013;coupled receptors on target cells and have the ability to recruit leukocytes to sites of injury. A recent study showed that chemokine receptor CXCR-2 initiated AF by triggering monocyte mobilization in mice (<xref ref-type="bibr" rid="B20">20</xref>). Another study revealed that the chemokine signaling pathway, CXCL12/CXCR4 axis, enhanced atrial inflammation and fibrosis by recruiting CD<sup>3&#x002B;</sup> T lymphocytes and F4/80&#x002B; macrophages (<xref ref-type="bibr" rid="B21">21</xref>). In addition, it was also found that chemokine CXCL10 contributed to atrial inflammation and AF (<xref ref-type="bibr" rid="B22">22</xref>). All the above evidences uncovered that the DEGs may enhance inflammatory response by regulating the infiltration of immune cells to promote AF.</p>
<p>To look for the key genes correlated with AF, a gene co-expression network was constructed by WGCNA. The genes from the module, which had the highest correlation with AF by WGCNA, were further analyzed by LASSO regression analysis. Finally, 4 Hub genes including PILRA, NCF2, EVI2B, and GAPT were found. To prove the validity of 4 Hub genes, we measured their expression levels between rats with AF and rats with sinus rhythm using qPCR. The results showed that only expression of PILRA was elevated in AF, consisting with bioinformatics analysis.</p>
<p>We further analyzed the types of immune cells with increased infiltration in AF. We found increased infiltration of activated CD<sup>4</sup> T cell, activated CD<sup>8</sup> T cell, activated dendritic cell, gamma delta T cell, immature B cell, MDSC, macrophage, mast cell, monocyte, neutrophil, plasmacytoid dendritic cell, regulatory T cell, type 17 T helper cell, effector memory CD<sup>4</sup> T cell, central memory CD<sup>4</sup> T cell, central memory CD<sup>8</sup> T cell, and effector memory CD<sup>8</sup> T cell in AF.</p>
<p>In the atrium of human with AF, cellular inflammation, mainly consisting of functional cytotoxic T lymphocytes, was observed (<xref ref-type="bibr" rid="B23">23</xref>). The peripheral percentage of Th1 cells, the absolute number of Th17 cells, and the ratio of Th1/Treg were associated with a significantly higher risk of AF in patients with rheumatoid arthritis (<xref ref-type="bibr" rid="B24">24</xref>). CD<sup>4&#x002B;</sup>CD<sup>28null</sup> T cells are associated with the development of AF after elective cardiac surgery (<xref ref-type="bibr" rid="B25">25</xref>). Similarly, CD<sup>8&#x002B;</sup>CD28<sup>null</sup> T cells are associated with the development of AF after elective cardiac surgery (<xref ref-type="bibr" rid="B26">26</xref>). These pieces of evidence showed that T cells and their subpopulations play an important role in inflammatory response to promote AF. Our results are similar to these previous reports. However, the effects of B cells and their subpopulation on inflammatory response leading to AF are still unknown.</p>
<p>The recruitment of monocytes/macrophages and neutrophils is enhanced in the atrial tissue of patients with AF or in angiotension II&#x2013;induced mouse AF model (<xref ref-type="bibr" rid="B27">27</xref>). Pressure overload induced mast cells infiltration and fibrosis in the atrium of mice and enhanced AF susceptibility following atrial burst stimulation (<xref ref-type="bibr" rid="B28">28</xref>). In addition, the infiltrated myeloid dendritic cells, migratory-active dendritic cells, and mature dendritic cells were significantly higher in left atrium of the patients with rheumatic heart disease than the patients without rheumatic heart disease, which was closely associated with inflammation and atrial remolding (<xref ref-type="bibr" rid="B29">29</xref>). In accordance with these results, our study uncovered that the infiltration of monocytes, macrophages, neutrophils, and dendritic cells was correlated with AF.</p>
<p>Moreover, PILRA was significantly and positively correlated with activated CD<sup>4</sup> T cell, activated CD<sup>8</sup> T cell, regulatory T cell, effector memory CD<sup>4</sup> T cell, effector memory CD<sup>8</sup> T cell, central memory CD<sup>4</sup> T cell, central memory CD<sup>8</sup> T cell, gamma delta T cell, immature B cell, monocyte, macrophage, mast cell, activated dendritic cell, and plasmacytoid dendritic cell. These results suggested that PILRA was an important regulator of infiltration of immune cells in AF.</p>
<p>PILR&#x03B1; encoded by PILRA was an inhibitory receptor containing immunoreceptor tyrosine-based inhibitory motifs (ITIMs), negatively regulated neutrophil infiltration during inflammation (<xref ref-type="bibr" rid="B30">30</xref>). It was also able to interact with CD<sup>8&#x03B1;</sup> to maintain CD<sup>8&#x002B;</sup> T cell quiescence (<xref ref-type="bibr" rid="B31">31</xref>). In addition, PILR&#x03B1; can inhibit monocyte migration into tissue and differentiation into macrophages through regulating integrin signaling and inhibiting CD<sup>99</sup>&#x2013;CD<sup>99</sup> binding (<xref ref-type="bibr" rid="B32">32</xref>). We speculate that the elevated level of PILRA in AF may be a compensatory mechanism to protect against inflammatory injury by preventing the activation of CD<sup>8&#x002B;</sup> T cells and monocyte. However, this compensatory power may be not enough to reverse the inflammatory injury led by other immune cells. This is similar to activation of natriuretic peptide system in heart failure. The increased level of brain natriuretic peptide is observed in patients with heart failure, but increased level of endogenous brain natriuretic peptide is not enough to improve the symptom of patients with heart failure. Moreover, administration of exogenous recombinant human brain natriuretic peptide can markedly alleviate the symptoms of heart failure. Therefore, we think that PILRA may be a novel target of intervention for AF. To the best of our knowledge, it is the first study to report that PILRA is a potential regulator of immune cells infiltration in AF. However, the effects of PILRA on infiltration of T cell subsets except CD<sup>8&#x002B;</sup> T cell, B cell, mast cell, and dendritic cell are needed to clarify.</p>
<p>Our research has several limitations. Firstly, it was a bioinformatics analysis. Although 2 GEO datasets were merged, and WGCNA and LASSO regression analysis were used to obtain the Hub genes of AF, the exact roles of 4 Hub genes in AF are needed to clarify by vitro and vivo studies. Secondly, the results of qPCR showed that elevated level of PILRA, but no significant difference among the expression levels of NCF2, EVI2B, and GAPT between the rats with and without AF were observed. Our results from a small sample animal study need extensive samples of atrial tissue of human with and without AF for validation. Finally, the elevated level of PILRA in AF was preliminary determined by qPCR, and the correlation between PILRA and infiltration of immune cells was obtained by bioinformatics analysis. Gain- and loss-of-function of PILRA in animal are needed to investigate the effects on immune cells infiltration and AF susceptibility, to further validate our conclusion.</p>
<p>In conclusion, PILRA was closely related to multiple types of immune cells infiltration, which may be associated with AF. PILRA may be a novel target of intervention for AF.</p>
</sec>
</body>
<back>
<sec id="s5" sec-type="data-availability"><title>Data availability statement</title>
<p>Publicly available datasets were analyzed in this study. This data can be found here: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/">http://www.ncbi.nlm.nih.gov/geo/</ext-link>, GSE41177 and GSE79768</p>
</sec>
<sec id="s6" sec-type="ethics-statement"><title>Ethics statement</title>
<p>The animal study was reviewed and approved by the Ethics Committee of Guangxi Medical University Laboratory Animal Center. Written informed consent was obtained from the owners for the participation of their animals in this study.</p>
</sec>
<sec id="s7" sec-type="author-contributions"><title>Author contributions</title>
<p>GZ and ZJ conceived and designed the study. WS, XL, YS, and SL preformed the data analysis and wrote the manuscript. DL, LW and WH performed the experiment. ZJ revised and reviewed the manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s8" sec-type="funding-information"><title>Funding</title>
<p>This study was supported by the National Natural Sciences Foundation of China (No. 82060068; 82160066).</p>
</sec>
<ack><title>Acknowledgments</title>
<p>We acknowledge the GEO database for providing meaningful datasets, and we acknowledge that English language was edited by professor Jiang-Zhang from Guangxi Medical University, who is jointly awarded PhD degree by University of Florence, University of Pisa and University of Siena in Italy.</p>
</ack>
<sec id="s9" sec-type="COI-statement"><title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chugh</surname><given-names>SS</given-names></name><name><surname>Havmoeller</surname><given-names>R</given-names></name><name><surname>Narayanan</surname><given-names>K</given-names></name><name><surname>Singh</surname><given-names>D</given-names></name><name><surname>Rienstra</surname><given-names>M</given-names></name><name><surname>Benjamin</surname><given-names>EJ</given-names></name><etal/></person-group> <article-title>Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study</article-title>. <source>Circulation</source>. (<year>2014</year>) <volume>129</volume>(<issue>8</issue>):<fpage>837</fpage>&#x2013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.113.005119</pub-id><pub-id pub-id-type="pmid">24345399</pub-id></citation></ref>
<ref id="B2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Staerk</surname><given-names>L</given-names></name><name><surname>Sherer</surname><given-names>JA</given-names></name><name><surname>Ko</surname><given-names>D</given-names></name><name><surname>Benjamin</surname><given-names>EJ</given-names></name><name><surname>Helm</surname><given-names>RH</given-names></name></person-group>. <article-title>Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes</article-title>. <source>Circ Res</source>. (<year>2017</year>) <volume>120</volume>(<issue>9</issue>):<fpage>1501</fpage>&#x2013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.309732</pub-id><pub-id pub-id-type="pmid">28450367</pub-id></citation></ref>
<ref id="B3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wijesurendra</surname><given-names>RS</given-names></name><name><surname>Casadei</surname><given-names>B</given-names></name></person-group>. <article-title>Mechanisms of atrial fibrillation</article-title>. <source>Heart (Br Cardiac Soc)</source>. (<year>2019</year>) <volume>105</volume>(<issue>24</issue>):<fpage>1860</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1136/heartjnl-2018-314267</pub-id></citation></ref>
<ref id="B4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nattel</surname><given-names>S</given-names></name></person-group>. <article-title>Molecular and cellular mechanisms of atrial fibrosis in atrial fibrillation</article-title>. <source>JACC Clin Electrophysiol</source>. (<year>2017</year>) <volume>3</volume>(<issue>5</issue>):<fpage>425</fpage>&#x2013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacep.2017.03.002</pub-id><pub-id pub-id-type="pmid">29759598</pub-id></citation></ref>
<ref id="B5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>SN</given-names></name><name><surname>Tsai</surname><given-names>CT</given-names></name><name><surname>Wu</surname><given-names>CK</given-names></name><name><surname>Lee</surname><given-names>JK</given-names></name><name><surname>Lai</surname><given-names>LP</given-names></name><name><surname>Huang</surname><given-names>SW</given-names></name><etal/></person-group> <article-title>A functional variant in the promoter region regulates the C-reactive protein gene and is a potential candidate for increased risk of atrial fibrillation</article-title>. <source>J Intern Med</source>. (<year>2012</year>) <volume>272</volume>(<issue>3</issue>):<fpage>305</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2796.2012.02531.x</pub-id><pub-id pub-id-type="pmid">22329434</pub-id></citation></ref>
<ref id="B6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>C</given-names></name><name><surname>Veleva</surname><given-names>T</given-names></name><name><surname>Scott</surname><given-names>L</given-names><suffix>Jr</suffix></name><name><surname>Cao</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><etal/></person-group> <article-title>Enhanced cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillation</article-title>. <source>Circulation</source>. (<year>2018</year>) <volume>138</volume>(<issue>20</issue>):<fpage>2227</fpage>&#x2013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.118.035202</pub-id><pub-id pub-id-type="pmid">29802206</pub-id></citation></ref>
<ref id="B7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Zhao</surname><given-names>Q</given-names></name></person-group>. <article-title>Immune remodeling and atrial fibrillation</article-title>. <source>Front Physiol</source>. (<year>2022</year>) <volume>13</volume>:<fpage>927221</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2022.927221</pub-id><pub-id pub-id-type="pmid">35936905</pub-id></citation></ref>
<ref id="B8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Langfelder</surname><given-names>P</given-names></name><name><surname>Horvath</surname><given-names>S</given-names></name></person-group>. <article-title>WGCNA: an R package for weighted correlation network analysis</article-title>. <source>BMC Bioinform</source>. (<year>2008</year>) <volume>9</volume>:<fpage>559</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2105-9-559</pub-id></citation></ref>
<ref id="B9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>J</given-names></name><name><surname>Soussen</surname><given-names>C</given-names></name><name><surname>Brie</surname><given-names>D</given-names></name><name><surname>Idier</surname><given-names>J</given-names></name><name><surname>Wan</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>YP</given-names></name></person-group>. <article-title>Generalized LASSO with under-determined regularization matrices</article-title>. <source>Signal Process</source>. (<year>2016</year>) <volume>127</volume>:<fpage>239</fpage>&#x2013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1016/j.sigpro.2016.03.001</pub-id></citation></ref>
<ref id="B10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>FC</given-names></name><name><surname>Lin</surname><given-names>YC</given-names></name><name><surname>Chang</surname><given-names>SH</given-names></name><name><surname>Chang</surname><given-names>GJ</given-names></name><name><surname>Hsu</surname><given-names>YJ</given-names></name><name><surname>Lin</surname><given-names>YM</given-names></name><etal/></person-group> <article-title>Differential left-to-right atria gene expression ratio in human sinus rhythm and atrial fibrillation: implications for arrhythmogenesis and thrombogenesis</article-title>. <source>Int J Cardiol</source>. (<year>2016</year>) <volume>222</volume>:<fpage>104</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijcard.2016.07.103</pub-id><pub-id pub-id-type="pmid">27494721</pub-id></citation></ref>
<ref id="B11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yeh</surname><given-names>YH</given-names></name><name><surname>Kuo</surname><given-names>CT</given-names></name><name><surname>Lee</surname><given-names>YS</given-names></name><name><surname>Lin</surname><given-names>YM</given-names></name><name><surname>Nattel</surname><given-names>S</given-names></name><name><surname>Tsai</surname><given-names>FC</given-names></name><etal/></person-group> <article-title>Region-specific gene expression profiles in the left atria of patients with valvular atrial fibrillation</article-title>. <source>Heart Rhythm</source>. (<year>2013</year>) <volume>10</volume>(<issue>3</issue>):<fpage>383</fpage>&#x2013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2012.11.013</pub-id><pub-id pub-id-type="pmid">23183193</pub-id></citation></ref>
<ref id="B12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mariam</surname><given-names>A</given-names></name><name><surname>Miller-Atkins</surname><given-names>G</given-names></name><name><surname>Moro</surname><given-names>A</given-names></name><name><surname>Rodarte</surname><given-names>AI</given-names></name><name><surname>Siddiqi</surname><given-names>S</given-names></name><name><surname>Acevedo-Moreno</surname><given-names>LA</given-names></name><etal/></person-group> <article-title>Salivary miRNAs as non-invasive biomarkers of hepatocellular carcinoma: a pilot study</article-title>. <source>PeerJ</source>. (<year>2022</year>) <volume>10</volume>:<fpage>e12715</fpage>. <pub-id pub-id-type="doi">10.7717/peerj.12715</pub-id><pub-id pub-id-type="pmid">35036096</pub-id></citation></ref>
<ref id="B13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>N</given-names></name><name><surname>Xiao</surname><given-names>J</given-names></name><name><surname>Narke</surname><given-names>D</given-names></name><name><surname>Shaheen</surname><given-names>D</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Offerman</surname><given-names>E</given-names></name><etal/></person-group> <article-title>Cardiac pressure overload decreases ETV1 expression in the left atrium, contributing to atrial electrical and structural remodeling</article-title>. <source>Circulation</source>. (<year>2021</year>) <volume>143</volume>(<issue>8</issue>):<fpage>805</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.120.048121</pub-id><pub-id pub-id-type="pmid">33225722</pub-id></citation></ref>
<ref id="B14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsushita</surname><given-names>N</given-names></name><name><surname>Ishida</surname><given-names>N</given-names></name><name><surname>Ibi</surname><given-names>M</given-names></name><name><surname>Saito</surname><given-names>M</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Taniguchi</surname><given-names>S</given-names></name><etal/></person-group> <article-title>IL-1&#x03B2; plays an important role in pressure overload-induced atrial fibrillation in mice</article-title>. <source>Biol Pharm Bull</source>. (<year>2019</year>) <volume>42</volume>(<issue>4</issue>):<fpage>543</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1248/bpb.b18-00363</pub-id><pub-id pub-id-type="pmid">30930414</pub-id></citation></ref>
<ref id="B15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kondo</surname><given-names>H</given-names></name><name><surname>Abe</surname><given-names>I</given-names></name><name><surname>Fukui</surname><given-names>A</given-names></name><name><surname>Saito</surname><given-names>S</given-names></name><name><surname>Miyoshi</surname><given-names>M</given-names></name><name><surname>Aoki</surname><given-names>K</given-names></name><etal/></person-group> <article-title>Possible role of rivaroxaban in attenuating pressure-overload-induced atrial fibrosis and fibrillation</article-title>. <source>J Cardiol</source>. (<year>2018</year>) <volume>71</volume>(<issue>3</issue>):<fpage>310</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.jjcc.2017.08.007</pub-id><pub-id pub-id-type="pmid">28993090</pub-id></citation></ref>
<ref id="B16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Zhong</surname><given-names>G</given-names></name><name><surname>Wen</surname><given-names>L</given-names></name><name><surname>Hong</surname><given-names>Y</given-names></name><name><surname>Fang</surname><given-names>S</given-names></name><name><surname>Sun</surname><given-names>P</given-names></name><etal/></person-group> <article-title>The role of platelet-derived growth factor-B/platelet-derived growth factor receptor-&#x03B2; signaling in chronic atrial fibrillation</article-title>. <source>Cardiology</source>. (<year>2016</year>) <volume>133</volume>(<issue>4</issue>):<fpage>242</fpage>&#x2013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1159/000442940</pub-id><pub-id pub-id-type="pmid">26752520</pub-id></citation></ref>
<ref id="B17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berraondo</surname><given-names>P</given-names></name><name><surname>Sanmamed</surname><given-names>MF</given-names></name><name><surname>Ochoa</surname><given-names>MC</given-names></name><name><surname>Etxeberria</surname><given-names>I</given-names></name><name><surname>Aznar</surname><given-names>MA</given-names></name><name><surname>P&#x00E9;rez-Gracia</surname><given-names>JL</given-names></name><etal/></person-group> <article-title>Cytokines in clinical cancer immunotherapy</article-title>. <source>Br J Cancer</source>. (<year>2019</year>) <volume>120</volume>(<issue>1</issue>):<fpage>6</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1038/s41416-018-0328-y</pub-id><pub-id pub-id-type="pmid">30413827</pub-id></citation></ref>
<ref id="B18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>H</given-names></name><name><surname>Xue</surname><given-names>YM</given-names></name><name><surname>Zhan</surname><given-names>XZ</given-names></name><name><surname>Liao</surname><given-names>HT</given-names></name><name><surname>Guo</surname><given-names>HM</given-names></name><name><surname>Wu</surname><given-names>SL</given-names></name></person-group>. <article-title>Role of tumor necrosis factor-alpha in the pathogenesis of atrial fibrillation</article-title>. <source>Chin Med J</source>. (<year>2011</year>) <volume>124</volume>(<issue>13</issue>):<fpage>1976</fpage>&#x2013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.3760/cma.j.issn.0366-6999.2011.13.010</pub-id><pub-id pub-id-type="pmid">22088456</pub-id></citation></ref>
<ref id="B19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lazzerini</surname><given-names>PE</given-names></name><name><surname>Laghi-Pasini</surname><given-names>F</given-names></name><name><surname>Acampa</surname><given-names>M</given-names></name><name><surname>Srivastava</surname><given-names>U</given-names></name><name><surname>Bertolozzi</surname><given-names>I</given-names></name><name><surname>Giabbani</surname><given-names>B</given-names></name><etal/></person-group> <article-title>Systemic inflammation rapidly induces reversible atrial electrical remodeling: the role of interleukin-6-mediated changes in connexin expression</article-title>. <source>J Am Heart Assoc</source>. (<year>2019</year>) <volume>8</volume>(<issue>16</issue>):<fpage>e011006</fpage>. <pub-id pub-id-type="doi">10.1161/JAHA.118.011006</pub-id><pub-id pub-id-type="pmid">31423933</pub-id></citation></ref>
<ref id="B20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>YL</given-names></name><name><surname>Cao</surname><given-names>HJ</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Teng</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><etal/></person-group> <article-title>Chemokine receptor CXCR-2 initiates atrial fibrillation by triggering monocyte mobilization in mice</article-title>. <source>Hypertension</source>. (<year>2020</year>) <volume>76</volume>(<issue>2</issue>):<fpage>381</fpage>&#x2013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.120.14698</pub-id><pub-id pub-id-type="pmid">32639881</pub-id></citation></ref>
<ref id="B21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Gao</surname><given-names>F</given-names></name><name><surname>Fu</surname><given-names>Y</given-names></name><etal/></person-group> <article-title>CXCL12/CXCR4 axis as a key mediator in atrial fibrillation via bioinformatics analysis and functional identification</article-title>. <source>Cell Death Dis</source>. (<year>2021</year>) <volume>12</volume>(<issue>9</issue>):<fpage>813</fpage>. <pub-id pub-id-type="doi">10.1038/s41419-021-04109-5</pub-id><pub-id pub-id-type="pmid">34453039</pub-id></citation></ref>
<ref id="B22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>D</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><etal/></person-group> <article-title>Serum extracellular vesicles containing MIAT induces atrial fibrosis, inflammation and oxidative stress to promote atrial remodeling and atrial fibrillation via blockade of miR-485-5p-mediated CXCL10 inhibition</article-title>. <source>Clin Transl Med</source>. (<year>2021</year>) <volume>11</volume>(<issue>8</issue>):<fpage>e482</fpage>. <pub-id pub-id-type="doi">10.1002/ctm2.482</pub-id><pub-id pub-id-type="pmid">34459123</pub-id></citation></ref>
<ref id="B23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haemers</surname><given-names>P</given-names></name><name><surname>Hamdi</surname><given-names>H</given-names></name><name><surname>Guedj</surname><given-names>K</given-names></name><name><surname>Suffee</surname><given-names>N</given-names></name><name><surname>Farahmand</surname><given-names>P</given-names></name><name><surname>Popovic</surname><given-names>N</given-names></name><etal/></person-group> <article-title>Atrial fibrillation is associated with the fibrotic remodelling of adipose tissue in the subepicardium of human and sheep atria</article-title>. <source>Eur Heart J</source>. (<year>2017</year>) <volume>38</volume>(<issue>1</issue>):<fpage>53</fpage>&#x2013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehv625</pub-id><pub-id pub-id-type="pmid">26612579</pub-id></citation></ref>
<ref id="B24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Fan</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Yin</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Gao</surname><given-names>C</given-names></name><etal/></person-group> <article-title>Elevated peripheral T helper cells are associated with atrial fibrillation in patients with rheumatoid arthritis</article-title>. <source>Front Immunol</source>. (<year>2021</year>) <volume>12</volume>:<fpage>744254</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2021.744254</pub-id><pub-id pub-id-type="pmid">34721413</pub-id></citation></ref>
<ref id="B25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sulzgruber</surname><given-names>P</given-names></name><name><surname>Thaler</surname><given-names>B</given-names></name><name><surname>Koller</surname><given-names>L</given-names></name><name><surname>Baumgartner</surname><given-names>J</given-names></name><name><surname>Pilz</surname><given-names>A</given-names></name><name><surname>Steininger</surname><given-names>M</given-names></name><etal/></person-group> <article-title>CD4(&#x002B;)CD28(null) T lymphocytes are associated with the development of atrial fibrillation after elective cardiac surgery</article-title>. <source>Sci Rep</source>. (<year>2018</year>) <volume>8</volume>(<issue>1</issue>):<fpage>9624</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-018-28046-0</pub-id><pub-id pub-id-type="pmid">29941960</pub-id></citation></ref>
<ref id="B26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kazem</surname><given-names>N</given-names></name><name><surname>Sulzgruber</surname><given-names>P</given-names></name><name><surname>Thaler</surname><given-names>B</given-names></name><name><surname>Baumgartner</surname><given-names>J</given-names></name><name><surname>Koller</surname><given-names>L</given-names></name><name><surname>Laufer</surname><given-names>G</given-names></name><etal/></person-group> <article-title>CD8&#x002B;CD28null T lymphocytes are associated with the development of atrial fibrillation after elective cardiac surgery</article-title>. <source>Thromb Haemostasis</source>. (<year>2020</year>) <volume>120</volume>(<issue>8</issue>):<fpage>1182</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1055/s-0040-1713096</pub-id></citation></ref>
<ref id="B27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>YL</given-names></name><name><surname>Lin</surname><given-names>QY</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Guan</surname><given-names>XM</given-names></name><name><surname>Ma</surname><given-names>XL</given-names></name><etal/></person-group> <article-title>CXCL1-CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration</article-title>. <source>Eur Heart J</source>. (<year>2018</year>) <volume>39</volume>(<issue>20</issue>):<fpage>1818</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehy085</pub-id><pub-id pub-id-type="pmid">29514257</pub-id></citation></ref>
<ref id="B28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>CH</given-names></name><name><surname>Akazawa</surname><given-names>H</given-names></name><name><surname>Tamagawa</surname><given-names>M</given-names></name><name><surname>Ito</surname><given-names>K</given-names></name><name><surname>Yasuda</surname><given-names>N</given-names></name><name><surname>Kudo</surname><given-names>Y</given-names></name><etal/></person-group> <article-title>Cardiac mast cells cause atrial fibrillation through PDGF-A-mediated fibrosis in pressure-overloaded mouse hearts</article-title>. <source>J Clin Invest</source>. (<year>2010</year>) <volume>120</volume>(<issue>1</issue>):<fpage>242</fpage>&#x2013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1172/JCI39942</pub-id><pub-id pub-id-type="pmid">20038802</pub-id></citation></ref>
<ref id="B29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shiba</surname><given-names>M</given-names></name><name><surname>Sugano</surname><given-names>Y</given-names></name><name><surname>Ikeda</surname><given-names>Y</given-names></name><name><surname>Okada</surname><given-names>H</given-names></name><name><surname>Nagai</surname><given-names>T</given-names></name><name><surname>Ishibashi-Ueda</surname><given-names>H</given-names></name><etal/></person-group> <article-title>Presence of increased inflammatory infiltrates accompanied by activated dendritic cells in the left atrium in rheumatic heart disease</article-title>. <source>PLoS One</source>. (<year>2018</year>) <volume>13</volume>(<issue>9</issue>):<fpage>e0203756</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0203756</pub-id><pub-id pub-id-type="pmid">30261069</pub-id></citation></ref>
<ref id="B30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Shiratori</surname><given-names>I</given-names></name><name><surname>Uehori</surname><given-names>J</given-names></name><name><surname>Ikawa</surname><given-names>M</given-names></name><name><surname>Arase</surname><given-names>H</given-names></name></person-group>. <article-title>Neutrophil infiltration during inflammation is regulated by PILR&#x03B1; via modulation of integrin activation</article-title>. <source>Nat Immunol</source>. (<year>2013</year>) <volume>14</volume>(<issue>1</issue>):<fpage>34</fpage>&#x2013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1038/ni.2456</pub-id><pub-id pub-id-type="pmid">23142774</pub-id></citation></ref>
<ref id="B31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Yao</surname><given-names>S</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Klement</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><etal/></person-group> <article-title>The CD8&#x03B1;-PILR&#x03B1; interaction maintains CD8(&#x002B;) T cell quiescence</article-title>. <source>Science (New York, NY)</source>. (<year>2022</year>) <volume>376</volume>(<issue>6596</issue>):<fpage>996</fpage>&#x2013;<lpage>1001</lpage>. <pub-id pub-id-type="doi">10.1126/science.aaz8658</pub-id></citation></ref>
<ref id="B32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kohyama</surname><given-names>M</given-names></name><name><surname>Matsuoka</surname><given-names>S</given-names></name><name><surname>Shida</surname><given-names>K</given-names></name><name><surname>Sugihara</surname><given-names>F</given-names></name><name><surname>Aoshi</surname><given-names>T</given-names></name><name><surname>Kishida</surname><given-names>K</given-names></name><etal/></person-group> <article-title>Monocyte infiltration into obese and fibrilized tissues is regulated by PILR&#x03B1;</article-title>. <source>Eur J Immunol</source>. (<year>2016</year>) <volume>46</volume>(<issue>5</issue>):<fpage>1214</fpage>&#x2013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1002/eji.201545897</pub-id><pub-id pub-id-type="pmid">26840635</pub-id></citation></ref></ref-list>
</back>
</article>